James Olen Armitage

James Olen Armitage's AcademicInfluence.com Rankings

James Olen Armitage

Philosophy

#3314

World Rank

#5381

Historical Rank

Logic

#1081

World Rank

#1720

Historical Rank

philosophy Degrees

James Olen Armitage

Biology

#4110

World Rank

#6176

Historical Rank

Pathology

#41

World Rank

#94

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

James Olen Armitage's Degrees

Doctorate Medicine University of Nebraska Medical Center
PhD Pathology University of Nebraska Medical Center

Why Is James Olen Armitage Influential?

(Suggest an Edit or Addition)

(See a Problem?)

James Olen Armitage's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) (9767)
A predictive model for aggressive non-Hodgkin's lymphoma. (1993) (4400)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. (2004) (3681)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. (2002) (2370)
A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project (1997) (1664)
Stromal gene signatures in large-B-cell lymphomas. (2008) (1611)
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. (2006) (1563)
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. (1997) (1487)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. (2004) (1410)
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. (1998) (1271)
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (2003) (1074)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) (948)
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. (2000) (936)
Molecular diagnosis of Burkitt's lymphoma. (2006) (871)
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. (1987) (776)
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (2015) (714)
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. (1998) (666)
Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group (2004) (651)
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. (2005) (650)
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. (2009) (643)
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. (2008) (612)
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer (1991) (491)
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. (2002) (422)
Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. (1988) (411)
Non-Hodgkin lymphoma (2003) (407)
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. (2005) (400)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. (2012) (386)
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. (2011) (358)
Mantle cell lymphoma-- an entity comes of age. (1996) (357)
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. (2003) (356)
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. (2010) (350)
The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. (1991) (337)
Abeloff's Clinical Oncology (2013) (327)
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. (2008) (318)
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. (2002) (305)
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. (2011) (293)
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. (2013) (288)
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. (2004) (284)
Allogeneic bone marrow transplantation for low-grade lymphoma. (1998) (274)
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. (1999) (272)
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (1997) (268)
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. (1988) (254)
Staging Non‐Hodgkin Lymphoma (2005) (250)
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. (1997) (245)
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. (2007) (243)
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. (1991) (239)
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. (1993) (239)
Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. (2001) (232)
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. (2006) (231)
Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age (1984) (226)
The hematologist and radiation casualties. (2003) (223)
Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. (2003) (222)
Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases (1985) (221)
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. (1991) (220)
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. (1989) (217)
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (2001) (215)
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. (1996) (201)
Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. (1986) (197)
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (1999) (194)
Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. (1998) (191)
Treatment of non-Hodgkin's lymphoma. (1993) (189)
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma (1989) (185)
Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (1998) (182)
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. (1999) (180)
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma. (2011) (180)
The clinical spectrum of Castleman's disease (2012) (180)
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. (2003) (179)
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. (1990) (178)
MYC and BCL2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab (2014) (175)
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. (1986) (171)
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients. (1993) (170)
BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab (2011) (170)
Early-stage Hodgkin's lymphoma. (2010) (169)
Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. (1999) (169)
Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma. (2005) (167)
Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. (1995) (167)
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. (1999) (164)
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. (1989) (162)
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group (2000) (158)
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. (1989) (154)
How I treat patients with diffuse large B-cell lymphoma. (2007) (153)
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma (2006) (150)
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. (2003) (150)
Lymphoma classification--the gap between biology and clinical management is closing. (1996) (148)
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. (2003) (146)
Primary mediastinal large B-cell lymphoma. (2015) (143)
Colony-stimulating factors for febrile neutropenia during cancer therapy. (2013) (141)
Myeloid growth factors. (2013) (141)
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. (1987) (134)
Non-Hodgkin lymphoma (2012) (133)
Clinical applications of hematopoietic growth factors. (1995) (132)
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (2011) (130)
Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project. (1997) (130)
Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (1982) (128)
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma (2005) (121)
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease. (1991) (121)
Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. (2012) (119)
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. (2013) (117)
Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project (2016) (115)
Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia (1978) (113)
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. (1991) (111)
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. (2015) (110)
Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma (2003) (108)
Regulatory and clinical considerations for biosimilar oncology drugs. (2014) (108)
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. (1989) (107)
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (103)
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. (1993) (102)
Effect of chemotherapy for the dysmyelopoietic syndrome. (1981) (102)
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. (1991) (102)
Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation (1990) (101)
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. (2012) (101)
Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen. (1984) (100)
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. (1995) (100)
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. (1999) (99)
Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. (1990) (98)
Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. (1989) (97)
Typhlitis in acute leukemia. Successful treatment by early surgical intervention (1979) (97)
Splenic rupture in patients with hematologic malignancies (1981) (96)
Interpretation of clinical trials in diffuse large-cell lymphoma. (1988) (94)
Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma (2008) (93)
Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue. (1987) (93)
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. (2000) (93)
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. (1996) (93)
The aggressive peripheral T‐cell lymphomas: 2017 (2017) (93)
Chromosomal abnormalities in Hodgkin's disease. (1989) (90)
B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases (2013) (88)
Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants (1993) (86)
Non-Hodgkin lymphoma: diagnosis and treatment. (2015) (85)
Feasibility of semen cryopreservation in patients with malignant disease. (1980) (85)
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease. (2002) (84)
Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. (2002) (83)
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (1999) (82)
Mantle zone lymphoma a clinicopathologic study of 22 cases (1990) (82)
Peripheral T‐cell lymphoma (1989) (80)
Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). (1988) (80)
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. (2002) (78)
Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. (1991) (78)
Translumbar inferior vena cava catheters for long-term venous access. (1990) (75)
Cryopreservation and infusion of autologous peripheral blood stem cells. (1990) (75)
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings (1987) (73)
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. (2000) (73)
Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents. (1999) (71)
Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas. (1987) (71)
Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. (2008) (70)
The aggressive peripheral T‐cell lymphomas: 2012 update on diagnosis, risk stratification, and management (2012) (69)
Central Nervous System Involvement in Patients with Diffuse Aggressive Non‐Hodgkin's Lymphoma (1991) (69)
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. (2006) (69)
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. (2001) (69)
My treatment approach to patients with diffuse large B-cell lymphoma. (2012) (69)
Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants. (1983) (69)
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. (1996) (68)
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. (1990) (68)
ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia (2007) (67)
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma. (2004) (67)
Bone marrow transplantation in the treatment of patients with lymphoma. (1989) (66)
Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantation. (1982) (65)
Phase I/II Trial of Multiple Dose 131Iodine-MAb LL2 (CD22) in Patients with Recurrent Non-Hodgkin's Lymphoma (2000) (65)
Towards understanding the peripheral T-cell lymphomas. (2004) (65)
Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant. (1981) (65)
Myeloid growth factors clinical practice guidelines in oncology. (2005) (65)
The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. (2009) (64)
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft (1994) (64)
Prognostic factors of chronic graft‐versus‐host disease after allogeneic blood stem‐cell transplantation (2005) (64)
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. (1993) (64)
Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. (1983) (63)
International analysis of the frequency and outcomes of NK/T-cell lymphomas. (2013) (63)
Recurrent abnormalities of chromosome bands 10q23–25 in non‐Hodgkin's lymphoma (1992) (62)
Adult Burkitt lymphoma: advances in diagnosis and treatment. (2008) (61)
Positron emission tomographic scans in lymphoma: convention and controversy. (2012) (61)
Atypical Lymphoproliferative Diseases. (2000) (61)
Long‐term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies (1992) (61)
Acute radiation injury: contingency planning for triage, supportive care, and transplantation. (2006) (61)
Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma (2007) (60)
Peripheral T‐cell lymphoma: A clinicopathologic study of 42 cases (1987) (59)
Fournier's gangrene complicating aggressive therapy for hematologic malignancy (1986) (58)
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. (1995) (58)
Remission of giant lymph node hyperplasia with anemia after radiotherapy (1979) (58)
Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. (1977) (57)
Lymphomatoid papulosis and progression to T cell lymphoma: an immunophenotypic and genotypic analysis. (1989) (57)
Autologous bone marrow transplants: Different indications in Europe and North America (1989) (57)
Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. (1988) (57)
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. (2004) (56)
Hypoplastic acute leukemia (1981) (56)
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. (1994) (55)
Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma. A Report of 21 Cases from the Nebraska Lymphoma Study Group (2003) (54)
Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project. (1999) (54)
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. (1993) (53)
Clinical significance of hematologic parameters in non‐Hodgkin's lymphoma at diagnosis (1991) (53)
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation. (1989) (53)
Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy (2015) (53)
Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue. (1988) (52)
Analysis of the presenting features of adult acute leukemia: The French‐American‐British classification (1981) (52)
Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study. (2009) (51)
Circulating CD20 and CD52 in patients with non‐Hodgkin's lymphoma or Hodgkin's disease (2003) (51)
Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska Lymphoma Study Group. (1990) (51)
The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma. (1988) (50)
A decade of progress in lymphoma: advances and continuing challenges. (2010) (49)
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. (2007) (49)
Diffuse Large B-cell Lymphoma: A Clinicopathologic Analysis of 444 Cases Classified According to the Updated Kiel Classification (2002) (48)
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. (2001) (48)
Peripheral T‐cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients (1993) (47)
Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia. (1980) (47)
Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists (2004) (46)
Blood Stem Cell Transplantation (1998) (46)
Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation. (1994) (46)
Successful hematopoietic stem‐cell transplantation in multicentric Castleman disease complicated by POEMS syndrome (2005) (46)
Reviews and Notes: Oncology: High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells (1992) (46)
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. (1991) (45)
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging. (1991) (45)
Management of Hodgkin lymphoma. (2006) (43)
Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma. (1999) (43)
Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. (1991) (43)
Non-Hodgkin's lymphomas of mantle zone origin. (1991) (43)
Richter's syndrome with different immunoglobulin light chain types. Molecular and cytogenetic features indicate a common clonal origin. (1992) (43)
Autologous transplantation for Hodgkin's disease: coming of age? (1994) (42)
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas (2007) (42)
High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma. (1986) (42)
Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia (2016) (42)
Acute coronary syndromes complicating the first infusion of rituximab. (2008) (41)
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis. (2006) (41)
Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma (1990) (41)
Fondaparinux‐associated heparin‐induced thrombocytopenia (2013) (41)
Liver disease complicating the management of acute leukemia during remission (1978) (41)
The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project (2012) (41)
Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. (1999) (40)
Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma. (1979) (40)
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). (2008) (40)
Autologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry. (1993) (40)
Report of the first workshop on prognostic factors in large-cell lymphomas. (1991) (40)
A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR) (2012) (39)
Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization. (2002) (39)
Initial and subsequent cytogenetic studies in malignant lymphoma (1987) (39)
Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy. (1991) (39)
Chromosomal abnormalities in indolent lymphoma. (1987) (37)
Diagnostic concurrence in the subclassification of adult acute leukemia using French‐American‐British criteria (1982) (37)
Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease. (1992) (37)
Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. (1987) (35)
Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation (2012) (35)
Soluble interleukin 2 receptors in patients with malignant lymphoma. (1988) (34)
Generic oncology drugs: are they all safe? (2016) (34)
Are We Prepared for Nuclear Terrorism? (2018) (34)
Di erent types of di use large b-cell lymphoma identi ed by gene expression pro ling (2000) (34)
Abeloff's Clinical Oncology (5th ed.) (2014) (33)
Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma. (2006) (33)
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies. (1995) (33)
Clinical Significance of the t(14;18) And BCL2 Overexpression in Follicular Large Cell Lymphoma (2000) (32)
Myeloid growth factors. (2009) (32)
Long-term relapse-free survival in adult acute lymphoblastic leukemia. (1985) (32)
Treatment of non-Hodgkin lymphoma (2000) (32)
The aggressive peripheral T‐cell lymphomas: 2015 (2015) (32)
THE USE OF PARTIALLY MATCHED, UNRELATED DONORS IN CLINICAL BONE MARROW TRANSPLANTATION (1985) (32)
Myeloid growth factors. Clinical practice guidelines in oncology. (2007) (32)
Characteristics and outcomes of diffuse large B‐cell lymphoma presenting in leukaemic phase (2012) (31)
Non‐Hodgkin's lymphoma (1996) (31)
High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma. (2001) (31)
Spurious elevation of the platelet count in acute leukemia. (1978) (31)
The aggressive peripheral T‐cell lymphomas: 2013 (2013) (30)
The role of mitoxantrone in non-Hodgkin's lymphoma. (2002) (30)
Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission (2014) (30)
Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project (2015) (30)
Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (1994) (29)
Burkitt lymphoma during pregnancy with bilateral breast involvement. (1977) (29)
Hematopoietic cell transplantation: progress and obstacles. (2007) (29)
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B‐cell lymphoma (2012) (29)
Follicular lymphoma: expanding therapeutic options. (2005) (29)
Is watch and wait still acceptable for patients with low-grade follicular lymphoma? (2016) (29)
Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care (2014) (29)
Autologous transplantation for Hodgkin's disease: coming of age? [editorial; comment] (1994) (28)
The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma (2013) (28)
ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients (2019) (28)
Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group (2004) (28)
Results of semen cryopreservation in young men with testicular carcinoma and lymphoma. (1986) (28)
Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States. (2018) (28)
Histologic grade does not predict prognosis in optimally treated, advanced‐stage nodular sclerosing Hodgkin's disease (1992) (27)
Malignant lymphoma, diffuse mixed small and large cell. A clinicopathologic study of 47 cases (1983) (27)
High-dose chemotherapy and autologous transplant with peripheral-blood stem cells. (1993) (27)
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (2011) (27)
Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. (1994) (27)
Phase I trial of 90Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation (2007) (26)
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation. (2000) (26)
Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy. (1980) (26)
Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. (2015) (26)
Epstein–Barr virus and Hodgkin’s lymphoma in Cairo, Egypt (2010) (26)
Autotransplantation in lymphoma: better therapy or healthier patients? (1991) (26)
Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations. (2002) (25)
Hematopoietic growth factors (1996) (25)
Graft versus host disease following transfusion of normal blood products to patients with malignancies (1987) (25)
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease. (2007) (25)
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. (1992) (25)
Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. (2004) (24)
Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients (2013) (24)
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome (2015) (24)
Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (2015) (24)
Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation (1995) (24)
Salvage Therapy for Hodgkin’s Lymphoma (2009) (24)
B-cell neoplasia. A conceptual understanding based on the normal humoral immune response. (1990) (24)
Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial. (2009) (23)
Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. (2010) (23)
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma. (2013) (23)
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia, Facts and Myths (2013) (23)
Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma: a Report of 21 Cases from the Nebraska Lymphoma Study Group (2004) (23)
Long-term toxicity of the treatment of Hodgkin's disease. (1998) (23)
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience. (1999) (23)
Bone marrow transplantation. (1994) (22)
Controversies in the treatment of early-stage Hodgkin's lymphoma. (2015) (22)
Bone marrow autotransplantation. (1989) (22)
Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project (2016) (22)
Cytopathology of opportunistic infection in bronchoalveolar lavage. (1987) (22)
Granulocyte‐macrophage colony‐stimulating factor as adjunct therapy in relapsed lymphoid malignancy: Implications for economic analyses of phase III clinical trials (1995) (22)
Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) (2010) (22)
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma. (2014) (21)
Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population‐based Study (2017) (21)
Myelodysplasia and acute leukemia after autologous bone marrow transplantation. (2000) (21)
Is there a place for routine imaging for patients in complete remission from aggressive lymphoma? (2006) (21)
Who benefits from surveillance imaging? (2012) (21)
Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy. (2007) (21)
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation. (1998) (21)
Hodgkin's disease: the role of bone marrow transplantation. (1990) (21)
The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma. (1991) (20)
Bronchoalveolar lavage in the assessment of pulmonary Hodgkin's disease. (1989) (20)
Late relapse in patients with diffuse large B‐cell lymphoma (2010) (20)
Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. (1990) (20)
Missing Y chromosomes in lymph nodes from patients with non-Hodgkin's lymphoma. (1987) (20)
Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations. (2020) (20)
Activity of interferon-α in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma (2000) (20)
Prognostic significance of clinical and pathologic features in diffuse large B‐cell lymphoma (1993) (19)
Role of radiation therapy in primary mediastinal large B‐cell lymphoma in rituximab era: A US population‐based analysis (2015) (19)
Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades. (2015) (19)
Relative frequency of non‐Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases (2016) (19)
International Collaborative Group against Primary CNS Lymphomas. (2003) (19)
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells. (1996) (19)
Remission maintenance of adult acute lymphoblastic leukemia. (1977) (19)
The changing classification of non‐Hodgkin's lymphomas (1997) (18)
Bone marrow transplantation for indolent lymphomas. (1993) (18)
Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma. (1990) (18)
Autotransplants: now and in the future. (1991) (18)
CD43 expression is associated with inferior survival in the non‐germinal centre B‐cell subgroup of diffuse large B‐cell lymphoma (2013) (18)
The use of peripheral stem cell support of high-dose chemotherapy. (1993) (18)
Role of autotransplantation in Hodgkin's disease. (1993) (18)
Translumbar inferior vena cava catheters: safety and efficacy in peripheral blood stem cell transplantation (1990) (18)
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. (1995) (18)
The use of rhIL‐3 for mobilization of peripheral blood The International Journal of Cell Cloning in previously treated patients with lymphoid malignancies (1992) (18)
Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma. (1993) (18)
Lymphoma 2006: classification and treatment. (2006) (18)
Early bone marrow transplantation in Hodgkin's disease. (1994) (17)
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. (1989) (17)
Natural Killer/T‐cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States (2018) (17)
Radioimmunotherapy with 131-I tositumomab enhanced survival in good prognosis relapsed and high-risk diffuse large B-cell lymphoma (DLBCL) patients receiving high-dose chemotherapy and autologous stem cell transplantation (2007) (17)
Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation. (1991) (17)
Cytogenetic abnormalities in noncutaneous peripheral T-cell lymphoma. (1986) (17)
Abeloff's Clinical Oncology: Fifth Edition (2013) (17)
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma. (2013) (16)
Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue. (1987) (16)
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non‐Hodgkin lymphoma (2018) (16)
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation. (2003) (16)
Clinicopathologic features and management of blastoid variant of mantle cell lymphoma (2015) (16)
Advances in follicular lymphoma. (2004) (16)
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group. (1994) (15)
Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists (2012) (15)
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease. (1988) (15)
Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute myeloid leukemia. (2014) (15)
Translumbar inferior vena cava catheters: experience with 58 catheters in peripheral stem cell collection and transplantation. (1990) (15)
Revisions of and clarifications to the ASCO conflict of interest policy. (2006) (15)
Pyoderma gangrenosum or cutaneous lymphoma: a difficult clinical diagnosis. (1988) (15)
Lymphoplasmacytic lymphoma. Report of a case with three monoclonal proteins derived from a single neoplastic clone (1986) (15)
Management of mantle cell lymphoma. (1998) (14)
High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphoma. (2011) (14)
Salvage therapy for patients with non-Hodgkin's lymphoma. (1990) (14)
Brentuximab vedotin desensitization in a patient with refractory Hodgkin's lymphoma (2015) (14)
Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system (2011) (14)
Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience (2016) (14)
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation. (2007) (14)
Esophageal involvement by non-Hodgkin's lymphoma. (1984) (14)
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells. (2016) (14)
T-cell/NK-cell lymphomas: a review. (2007) (13)
Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma. (1998) (13)
The undifferentiated malignant neoplasm. Identification of lymphoma arising in skeletal muscle by immunohistochemical analysis. (1985) (13)
Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia (2018) (13)
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. (2019) (13)
A new approach to non-Hodgkin's lymphoma. (2000) (13)
BCL 2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma (2016) (13)
Harvesting marrow for autologous transplantation from patients with malignancies. (1987) (13)
Treatment of Indolent Non-Hodgkin’s Lymphoma with Cladribine as Single-Agent Therapy and in Combination with Mitoxantrone (2004) (13)
Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults. (1982) (13)
Clinical outcome of peripheral blood stem cell support (1994) (13)
Self-limited TTP-like syndrome after bee sting. (1979) (13)
Reassessments of ESAs for cancer treatment in the US and Europe. (2010) (13)
Staging and prognosis (2013) (12)
Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas. (2002) (12)
The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL) (2004) (12)
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. (2021) (12)
Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work). (2004) (12)
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion. (2007) (12)
Prognostic factors influencing survival in patients with B‐cell small lymphocytic lymphoma (2004) (12)
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy. (1996) (12)
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT) (2013) (12)
Ethical and financial issues in autologous marrow transplantation: a symposium sponsored by the University of Nebraska Medical Center. (1986) (12)
Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project (2015) (12)
ALK-negative Anaplastic Large-cell Lymphoma (ALCL) is Clinically and Immunophenotypically Different from both ALK-positive ALCL and Peripheral T-cell Lymphoma, Not Otherwise Specified: Report from the International Peripheral T-Cell Lymphoma Project (2008) (12)
Peripheral stem cell transplantation for patients with non‐hodgkin lymphoma (1992) (11)
Surgical intervention in complications of acute leukemia. (1980) (11)
Is there a role for autotransplants in acute leukemia? (1989) (11)
The present status of therapy for patients with aggressive non-Hodgkin's lymphoma. (1991) (11)
'Staging' systems for aggressive non-Hodgkin's lymphoma. (1992) (11)
Cytogenetic abnormalities in B-immunoblastic lymphoma. (1994) (11)
Chemotherapy for non-Hodgkin's lymphoma. (1992) (11)
Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia (2019) (11)
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes. (2020) (11)
Reasons for failure of MOPP to cure Hodgkin's disease The importance of dose and schedule (1982) (11)
Maintenance therapy of adult acute nonlymphoblastic leukemia. An argument against the need for central nervous system prophylaxis (1978) (11)
Leukemic diffuse large B-cell lymphoma in a patient with myeloproliferative disorder. (2015) (11)
Current therapy for cancer (1994) (11)
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors (2000) (11)
Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma. (1992) (11)
Surveillance imaging for lymphoma: pros and cons. (2014) (11)
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress. (2005) (10)
Myeloid metaplasia and osteolytic lesions. (1978) (10)
Clinical and Pathological Differences between Nasal and Nasal-Type NK/T Cell Lymphomas: A Summary of 136 Cases from the International T Cell Lymphoma (ITCL) Project. (2006) (10)
Ten years of international primary CNS lymphoma collaborative group studies. (2013) (10)
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma. (1995) (10)
Trends in Use of Radiation Therapy for Hodgkin Lymphoma From 2000 to 2012 on the Basis of the National Cancer Data Base. (2016) (10)
High dose cyclophosphamide, etoposide and carmustine and peripheral stem cell transplantation for patients with relapsed hodgkin disease and bone marrow abnormalities (1992) (10)
Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: A comparison with a standard centrifugation apheresis procedure (1990) (10)
Emergency response to radiological and nuclear accidents and incidents (2019) (10)
Salvage therapy for patients with lymphoma. (1994) (10)
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation. (1990) (10)
The History of Autologous Hematopoietic Cell Transplantation (2009) (9)
Treatment strategies for patients with relapsed or refractory Hodgkin's disease. (1995) (9)
Allogeneic transplantation following failure of autologous transplantation for lymphoma. (1998) (9)
Is lymphoma occurring in the elderly the same disease? (2008) (9)
Heparin-induced thrombocytopenia after bone marrow transplantation: report of two cases. (1994) (9)
The use of granulocyte-macrophage colony-stimulating factor in bone marrow transplantation. (1992) (9)
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients. (1993) (9)
Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. (1995) (9)
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma? (2013) (9)
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component (2009) (9)
Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma. (2016) (8)
Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline‐Based Therapy (2017) (8)
Treatment of refractory adult acute nonlymphoblastic leukemia with subcutaneous 5-azacytidine. (1977) (8)
The therapy of non-Hodgkin's lymphomas. Introduction and overview. (1991) (8)
Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-Hodgkin's lymphoma. (1987) (8)
Clinical or survival benefit to routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. (2013) (8)
Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification (2015) (8)
Treatment Patterns and Outcomes in Early‐stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis (2017) (8)
CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience (2002) (8)
Sarcoidosis mimicking recurrent lymphoma (2012) (8)
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. (1998) (8)
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA. (2017) (8)
Syndrome of thrombocytopenia and absent radii: qualitatively normal platelets with remission following spenectomy. (2009) (8)
Synchronous or Metachronous Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: A Case Series and Literature Review (2017) (8)
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization. (1995) (8)
Central nervous system involvement as a presenting feature of acute monocytic leukemia: preceding leukemia by 12 months. (1983) (8)
The curability of follicular lymphoma. (2007) (8)
Phase I/II Trial of Ofatumumab/Lenalidamide for Patients with Relasped/Refractory B-Cell Non-Hodgkin Lymphoma: High Response Rate in Indolent Lymphoma (2012) (7)
Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma. (2018) (7)
Approach to the Patient With Lymphadenopathy and Splenomegaly (2012) (7)
Current status of allogeneic and autologous blood and marrow transplantation: Report from the IBMTR and ABMTR — North America (1996) (7)
Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752). (1976) (7)
Salvage therapy for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. (1987) (7)
Oxford Textbook of Oncology, Second Edition (2002) (7)
Identical twin bone marrow transplantation for hairy cell leukemia. (1984) (7)
Autologous Hematopoietic Cell Transplantation for Non‐Hodgkin's Lymphoma (2007) (7)
Diffuse large B-cell lymphoma of the breast: a distinct entity? (2008) (7)
DIFFUSE ALVEOLAR HEMORRAGE IN AUTOLOGOUS BONE MARROW TRANSPLANT RECIPIENTS. REPLY (1991) (7)
Association of number of follow-up providers with outcomes in survivors of hematologic malignancies (2010) (7)
Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (2015) (7)
A new look at an old syndrome. (2012) (7)
Autologous bone marrow transplantation for Hodgkin's disease. (1992) (7)
High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease. (2006) (7)
The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL). (2004) (6)
Modern chemotherapeutic regimens in the management of aggressive non-Hodgkin lymphoma: can they be improved? (1991) (6)
Activity of interferon-alpha in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma. (2000) (6)
Do pathologic features predict prognosis in diffuse large B-cell lymphoma? (1987) (6)
Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics. (1995) (6)
Which Anti-CD20 Antibody Is Better in Follicular Lymphoma? (2017) (6)
Current and emerging treatment options for a patient with a second relapse of Hodgkin’s lymphoma (2018) (6)
Tumor proliferative rate and response to chemotherapy. (1992) (6)
Peripheral T-cell lymphomas: their time has come. (2009) (6)
Thoracic complications related to bone marrow transplantation. (1999) (6)
Survival of Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Effect of Using Multiagent Versus Single-agent Chemotherapy. (2020) (6)
Hematopoietic stem cell transplantation in hematologic malignancy. (2004) (6)
Chromosomal abnormalities in malignant lymphoma and Hodgkin's disease. (1991) (6)
Estimating the State-Level Supply of Cancer Care Providers: Preparing to Meet Workforce Needs in the Wake of Health Care Reform. (2015) (6)
Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone. (1978) (6)
To Surveil or Not to Surveil. (2015) (6)
Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphoma. (2019) (6)
[Reproducibility and prognostic value of histopathological classifications of malignant lymphomas. Prolegomena for the 1st international classification proposed by WHO. Group of the non-Hodgkin's Malignant Lymphoma Classification Project]. (1998) (6)
Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project (2015) (6)
Demographic and other characteristics of nodal non-Hodgkin’s lymphoma managed in academic versus non-academic centers (2015) (6)
Pulmonary emboli in patients receiving chemotherapy for non-Hodgkin's lymphoma. (1988) (5)
Autologous bone marrow transplantation for Hodgkin's disease. (1995) (5)
Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (1993) (5)
Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types. (1991) (5)
Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin's lymphoma--results from an expert meeting. (2003) (5)
Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposures (2021) (5)
Identification of clinically distinct types of diffuse large B-cell lymphoma based on gene expressio (2000) (5)
Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB) (2015) (5)
Looking back (and ahead) at salvage treatment for non-Hodgkin lymphoma. (2009) (5)
Autologous Transplant Event-Free Survival (EFS) Following Failure of CHOP-Rituximab (CHOP-R) for Diffuse Large B-Cell Lymphoma (DLBCL) Is the Same as the EFS Following Failure of CHOP Alone. (2004) (5)
The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphoma. (1993) (5)
The effectiveness of tositumomab and iodine I 131 tositumomab in relapsed/refractory follicular grade 1/2 and small lymphocytic non-Hodgkin's lymphoma (NHL). (2004) (5)
Mobilized versus non-mobilized peripheral stem cell transplantation after high dose therapy for low grade nonhodgkin lymphoma: Effect on failure-free survival (1998) (5)
Proliferative fraction and DNA content are lower in B-cell non-Hodgkin's lymphomas with the t(14;18). (1995) (5)
Text Atlas of Lymphomas (1999) (5)
The development of bone marrow transplantation as a treatment for patients with lymphoma--twentieth Richard and Hinda Rosenthal Foundation Award Lecture. (1997) (5)
What is the role of third generation regimens for initial therapy of non-Hodgkin's lymphomas? (1993) (4)
Phase I/II Study of Velcade®-Beam (V-Beam) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed Indolent Non-Hodgkin'S Lymphoma (NHL), Transformed or Mantle Cell Lymphoma (MCL) (2012) (4)
Point mutations and genomic deletions in Cyclin D1 create stable truncated mRNAs that are associated with increased proliferation rate and shorter survival in mantle cell lymphoma Lymphoma/Leukemia Molecular Profiling (2007) (4)
Rituximab maintenance therapy in diffuse large B-cell lymphoma: is XY the most important variable? (2015) (4)
TREATMENT OF ADVANCED HODGKIN’S DISEASE (1977) (4)
Surveillance in Patients With Diffuse Large B Cell Lymphoma. (2020) (4)
Idiopathic thrombocytopenic purpura in patients with histoplasmosis. (1977) (4)
Pilot study of the DHAP rescue protocol and of a new conditioning regimen in responding NHL, at relapse (1989) (4)
Bone marrow transplantation in chronic lymphocytic leukemia and lymphomas. (1996) (4)
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Diffuse Large-Cell Lymphoma, April 19-21, 1998, Lyon, France (1998) (4)
Are We Prepared for Nuclear Terrorism? (2018) (4)
Clinical roundtable monograph. T-cell lymphoma: therapeutic overview and disease state awareness. (2010) (4)
Bone marrow transplantation in the treatment of lymphoma (1990) (4)
Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma. (2004) (4)
Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma (2007) (4)
Cytomegalovirus cecal erosion causing massive hemorrhage in a bone marrow transplant recipient (1982) (4)
Non-Hodgkin's Lymphomas (2012) (4)
Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma? (1992) (4)
Phase II multi-center study of ruxolitinib phosphate for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (PTCL). (2019) (4)
Bone marrow transplantation in the treatment of Hodgkin's lymphoma: problems, remaining challenges, and future prospects. (1989) (4)
Chromosomal abnormalities in patients with non-cutaneous T-cell non-Hodgkin's lymphoma. The Nebraska Lymphoma Study Group. (1990) (4)
A call for HoLEP: AEEP for mega-prostates (≥ 200 cc) (2021) (3)
Comprar Abeloff´s Clinical Oncology - Expert consult print + online | W. Gillies McKenna | 9780443066948 | Churchill Livingstone (2008) (3)
Haploidentical Transplantation (2018) (3)
Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis. (2019) (3)
Nonheparin anticoagulants for heparin-induced thrombocytopenia. (2013) (3)
Bone marrow transplantation for Hodgkin's disease and lymphoma. (1993) (3)
A retrospective analysis of reported errata in five leading medical journals in 2012 (2014) (3)
Granulocyte-macrophage colony-stimulating factor (GM-CSF): answers or more questions? (1992) (3)
Prognostic Significance of Circulating Lymphoma Cells in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL). (2009) (3)
Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database. (2016) (3)
Goals of a lymphoma classification for the oncologist (1999) (3)
PET scans: when and how? (2011) (3)
Comprar Abeloff's Clinical Oncology Expert Consult Premium Edition: Enhanced Online Features and Print | W. Gillies McKenna | 9780443066955 | Churchill Livingstone (2008) (3)
25 Years Later: Endangered Species or Successful Evolution? (2011) (3)
Clinicopathologic Features, Management and Outcomes of Blastoid Variant (BV) of Mantle Cell Lymphoma (MCL): A Nebraska Lymphoma Study Group (NLSG) Experience (2014) (3)
Acute promyelocytic leukemia. (1975) (3)
Myeloid growth factors. (2011) (3)
Acute leukemia presenting with pericardial involvement. (1976) (3)
Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia. (2022) (3)
treatment outcome. The Nebraska Lymphoma Study Group lymphoma: associations with histology, clinical characteristics, and Chromosomal abnormalities in untreated patients with non-Hodgkin's (2011) (3)
Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation. (2000) (3)
Potential Pathogenetic Role of Achromobacter (Alcaligenes) Xylosoxidans in Primary Extranodal Marginal Zone Lymphoma of the Lung (BALT-Lymphoma): Update of the Results of a Retrospective Analysis on Behalf of IELSG (2011) (3)
Practice gaps and barriers to optimal care of hematologic malignancies in the United States. (2014) (3)
Transplantation in Lymphoma (1999) (3)
Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell non-Hodgkin lymphoma? (1999) (3)
Advances in the management of patients with non-Hodgkin’s lymphoma (2001) (3)
Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes (2020) (3)
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions (2019) (3)
Peripheral T-Cell Lymphoma-A Brief Review. (1990) (3)
Cell and Gene Therapies (2019) (3)
Hodgkin's disease presenting as a thyroid mass. (1982) (3)
A comparison of bone marrow transplantation with maintenance chemotherapy for patients with acute nonlymphoblastic leukemia in first complete remission (1984) (3)
Basic References (3)
Gene expression distinguishes Burkitt lymphoma from other aggressive lymphomas and identifies patients who are highly curable with intensive chemotherapeutic regimens. (2005) (3)
Molecular advances come of age. (2013) (2)
High-Dose Therapy (HDT) with Hematopoietic Stem Cell Transplantation (HSCT) is effective therapy for patients with Non-Hodgkin Lymphoma (NHL) and Central Nervous System (CNS) involvement (2010) (2)
Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL (2022) (2)
Allogeneic bone marrow transplantation (BMT) for the treatment of acute leukemia (1981) (2)
Long term outcome following autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma (2004) (2)
Use of Digital Technology to Optimize Functional Status in an Older Patient With Myelodysplastic Syndrome. (2017) (2)
Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults (2017) (2)
Long-term outcomes of rituximab use prior to autologous stem cell transplant (ASCT) in low-grade follicular lymphoma (FL) at the time of first progression. (2015) (2)
Elevated Serum Level of Fas Ligand Correlates With the Asymptomatic Stage of Human Immunodeficiency Virus Infection (1997) (2)
Myeloid Growth FactorsPractice Guidelines in Oncology (2011) (2)
Venetoclax in chronic lymphocytic leukaemia: a possible cure? (2018) (2)
Increasing complexity of high‐grade B‐cell lymphomas (2014) (2)
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: issues and controversies. (1991) (2)
New approaches to therapy in patients with lymphoma (1991) (2)
Comprar Abeloff's Clinical Oncology, 5th Edition | John Niederhuber | 9781455728657 | Saunders (2013) (2)
Comprar Abeloff's Clinical Oncology, 5th Edition | John Niederhuber | 9781455728657 | Saunders (2013) (2)
Circulating tumor DNA in lymphomas: Era of precision medicine (2020) (2)
Center Effect and Socioeconomic Determinants of Overall Survival (OS) of Diffuse Large B Cell Lymphoma (DLBCL) (2016) (2)
Do you know TAFRO? (2018) (2)
Serum Ig abnormalities in mantle cell lymphoma [7] (multiple letters) (1997) (2)
Managing Risk in Hodgkin Lymphoma. (2015) (2)
Effect of follow-up provider source on outcomes of patients with hematologic malignancies receiving hematopoietic stem cell transplantation. (2006) (2)
Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE) (2015) (2)
Report of the fifteenth international symposium of the foundation for promotion of cancer research: new horizons in the diagnosis and treatment of hematological malignancies based on molecular genetic features. (2002) (2)
Advance care planning (ACP) prior to hematopoeitic stem cell transplantation (HSCT) in patients with cancer is associated with improved survival (2007) (2)
The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma (2011) (2)
Nodular mixed lymphoma. A curable disease (1982) (2)
Lack Of Clinical Benefit For Routine Surveillance Imaging For Diffuse Large B-Cell Lymphoma In First Complete Remission (2013) (2)
Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning. (2005) (2)
NK-Cell Lymphoma Shares Strikingly Similar Molecular Features with a Distinct Set of γδ T-Cell Lymphoma and Identification of Aurora Kinase A Inhibitor as a Novel Therapeutic Agent. (2009) (2)
Postleukemic dysmyelopoiesis (1983) (2)
Reduced intensity treatment in early-stage Hodgkin's lymphoma (2011) (2)
Tissue microarray in a subset of South African patients with DLBCL. (2013) (2)
NCCN Myeloid Growth Factors Clinical Practice Guidelines in Oncology (2011) (1)
Long term disease free survival in patients with mantle cell lymphoma following hematopoietic stem cell transplantation (2004) (1)
The use of GM-CSF in bone marrow transplantation. (1991) (1)
Targeted therapy and hematological malignancy (2009) (1)
Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL) (2016) (1)
Myeloablative regimens in peripheral stem cell transplantation. (1992) (1)
Management of patients with peripheral T-cell lymphoma (2009) (1)
TRANSPLANTATION FOR HODGKIN'S DISEASE AND LYMPHOMA (1993) (1)
Lymphoma with Features Intermediate Between DLBCL and Burkitt Lymphoma: Better Outcome with Intensive Chemotherapy Regimens (2011) (1)
lymphoma by immunohistochemistry using a tissue microarray Confirmation of the molecular classification of diffuse large B-cell (2013) (1)
SYMPOSIUM ON ONCOLOGY PRACTICE: HEMATOLOGICAL MALI NANCIES (2006) (1)
Genomic analysis of lymphoma: potential for clinical application. (2010) (1)
Patients with Follicular Lymphoma, Grade 3, Have a Prolonged Relapse-Free Survival Following Aggressive Combination Chemotherapy. (2004) (1)
Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era? (2013) (1)
Clinical prognostic factors are stronger predictors of outcome in non-Hodgkins lymphoma than pathological subtypes (1996) (1)
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies. (1996) (1)
Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy (2013) (1)
| Textbook of Medical Oncology | Taylor & Francis Group (2009) (1)
Minimal residual disease: lessons to be learned from malignant lymphoma. (1990) (1)
Nosocomial legionnaires' disease. Occurrence in recipients of bone nmarrow transplants (1983) (1)
Proceedings of the 12th Biennial Congress -- South African Lymphoma Study Group. (2007) (1)
#461 Cytogenetic abnormalities in tumors from children with non-Hodgkinʼs lymphoma (NHL) or Hodgkinʼs disease (HD): Nebraska Lymphoma Study Group experience (1999) (1)
Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). (2007) (1)
American Society of Clinical Oncology: Where Have We Been? Where Are We Going? (1998) (1)
The treatment of patients with aggressive non-Hodgkin's lymphoma. (2005) (1)
Effect of geriatric assessment (GA) and genetic profiling on overall survival (OS) of older adults with acute myeloid leukemia (AML). (2021) (1)
Comprar Textbook of Medical Oncology. 4th Ed. | James O. Armitage | 9780415477482 | Informa Healthcare (2009) (1)
Allogeneic Stem Cell Transplantation for Multiple Myeloma: A 34-Year Experience (2018) (1)
Psycho-Oncology and Communication (2009) (1)
Preliminary quality-of-life findings of patients undergoing hematopoietic stem cell transplant utilizing the city of hope national medical center and functional assessment of cancer therapy instruments (2003) (1)
Allogeneic transplantation for mantle cell lymphoma (2004) (1)
Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin. (1993) (1)
Early bone marrow transplantation for patients with potentially curable malignancies. (1991) (1)
National Trend in Splenectomy for Splenic Marginal Zone Lymphoma (SMZL): An Analysis of Surveillance, Epidemiology and End Results (SEER) Database (2015) (1)
New frontiers in cancer chemotherapy? (1986) (1)
Phase II trial for lenalidomide alone in relapsed/refractory aggressive non-Hodgkin lymphoma (2007) (1)
Who benefits from surveillance imaging in lymphoma? (2013) (1)
The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL) (2010) (1)
Clinically important variants of diffuse large B-cell lymphoma. (2013) (1)
Frontline management of Hodgkin lymphoma patients with high-risk disease (2015) (1)
Cancer care—The relation between resources and outcome (2009) (1)
Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT). (2005) (1)
Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study. (2017) (1)
Therapeutic Approaches to Burkitt’s Lymphoma (2013) (1)
Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group. (2007) (1)
Non-Hodgkin's lymphoma: treatment of large cell lymphomas. (1994) (1)
Phase I trial with IPI-504 in relapsed/refractory multiple myeloma (2007) (1)
Prognostic role of at-diagnosis positron emission tomography (PET) scan in follicular lymphoma grade 3 (FL3). (2015) (1)
Assessment of Time to CAR-T Cell Therapy and Patients’ Outcomes in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Based on Insurance Status (Public Versus Private) and Distance Traveled to Treatment Center (2021) (1)
Quality of life, spiritual well-being, and survival post-hematopoietic stem cell transplantation (2006) (1)
Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma (2008) (1)
The place of transplantation in mantle cell lymphoma. (2013) (1)
Seminars in Oncology: Introduction (2004) (1)
Haematological cancer: Staging and restaging patients with lymphoma — a better approach? (2017) (1)
Recent progress in B- and T-cell lymphomas. (1994) (1)
Follicular large cleaved cell (centrocytic) lymphoma: A distinctive but unrecognized variant of follicular lymphoma (2017) (1)
Lymphoma Nomenclature ‐ What's in a name? (2022) (1)
Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma. (2004) (1)
Allogeneic bone marrow transplantation: problems and prospects. (1992) (1)
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma (2021) (1)
Can Elimination of Total Body Irradiation (TBI) in Conditioning Regimens for Autologous Stem Cell Transplantation (SCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma Decrease the Risk of Secondary AML/MDS(sAML/MDS)? A Retrospective Case-Control Study at the University of Nebraska Medical Center. (2005) (1)
The evolving role of autologous hematopoietic stem cell transplantation for the treatment of patients with lymphoma. (2003) (1)
Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study (2008) (1)
Commentary (Armitage): Chemotherapy of Intermediate-Grade Non-Hodgkin's Lymphoma: Is "More" or "Less" Better? (1995) (0)
Proceedings and abstracts of the 10th International Conference on Malignant Lymphoma, 4-7 June 2008, Lugano, Switzerland. (2008) (0)
Addition of tumor bulk to the International Prognostic Index (IPI) does not improve prognostication in diffuse large B-cell Lymphoma (DLBCL). (2006) (0)
Rituximab Added to Aggressive Chemotherapy Improves the Outcome of Patients with Follicular Lymphoma, Grade 3 and Results In Survival Comparable to Diffuse Large B-Cell Lymphoma. (2010) (0)
Mantle cell lymphoma: initial report from the North American Mantle Cell Lymphoma Consortium. (2020) (0)
Diagnosis and Treatment of Non-Hodgkin’s Lymphoma of Adults (2013) (0)
Proceedings of the 13th biennial South African Lymphoma Study Group Meeting--Cape Town October 2008. (2010) (0)
From the Early Days in Oncology to Now (2014) (0)
Generic drugs in oncology - Authors' reply. (2017) (0)
Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML) (2019) (0)
Academic Centers Are Associated with Improved Survival Outcomes in High Risk Diffuse Large B-Cell Lymphoma Patients (2018) (0)
Survival of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) and peripheral T-cell lymphoma (PTCL): A propensity matched analysis of the Surveillance, Epidemiology and End Results (SEER) database. (2015) (0)
Developing a Bone Marrow Transplantation Unit (1990) (0)
The use of pretreatment prognostic variables to predict outcome in diffuse histiocytic lymphoma (DHL) treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) (1981) (0)
Improving therapy for patients with aggressive lymphoma. (2011) (0)
Epidemiology and Etiology (2003) (0)
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation (2013) (0)
JAMA Peer Reviewers in 2018. (2019) (0)
Aggressive Large-Cell Lymphomas (2003) (0)
The Stanford V Regimen Is an Effective Treatment for Good Prognosis Patients with Hodgkin’s Disease. (2007) (0)
Utilization of Palliative Care in Diffuse Large B Cell Lymphoma Patients Is Linked to Insurance Type and Household Income (2022) (0)
Impact of rituximab on the course of low-grade follicular lymphoma. (2013) (0)
Incidence and Impact of Central Nervous System Complications on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience (P07.006) (2013) (0)
Nonmyeloablative allogeneic stem cell transplantation (NST) for lymphoid malignancies using pentostatin/low-dose total body irradiation (2004) (0)
Preliminary results of new therapies in the areas of cytotoxic agents and immunotherapy for advanced indolent lymphomas (0)
Treatment-Relate d M yelodysplasia a nd A cute L eukemia i n Non-Hodgkin's L ymphoma P atients (2003) (0)
Announcing a new series: Understanding unusual dysproteinemias. (2013) (0)
Autologous Bone Marrow Transplantation for Lymphoid Malignancies: The Use of Hematopoietic Growth Factors (1994) (0)
Report o f a n I nternational W orkshop t o S tandardize Response C riteria f or N on-Hodgkin's L ymphomas (1999) (0)
FDG-PET in Peripheral T-Cell Lymphoma. (2006) (0)
Assessment of Time to Insurance Approval and Distance Traveled in Patients Treated with CAR T-Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (2020) (0)
Treatment trends and outcomes in early-stage Hodgkin lymphoma in elderly: A National Cancer Data Base analysis. (2016) (0)
Clinical Relevance of Soluble HLA-I as Compared to b2-MicroglobulinLevels in Non-Hodgkin’s Lymphoma and Hodgkin’s Disease. (2004) (0)
Role of radiation (RT) in primary mediastinal large B-cell lymphoma (PMBCL): An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. (2015) (0)
Hodgkin lymphoma (2020) (0)
Primary Therapy for Patients with Malignant Lymphoma (1993) (0)
Announcing a new series: challenging situations in the management of leukemias. (2012) (0)
Bone Marrow Transplantation for Peripheral T-cel l Lymphoma in Children and Adolescents (2003) (0)
Are preclinical research findings replicable: An empirical analysis based on EpoR studies in cancer. (2014) (0)
Reviewers for the Journal, July-December 2017. (2019) (0)
Directing treatment by molecular subtype in diffuse large B-cell lymphoma: ready for primetime? (2014) (0)
Restrospective on the last quarter-century in hematologic oncology. (2011) (0)
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma? (2022) (0)
Low molecular weight heparin (LMWH) use in patients with hematologic malignancy-associated venous thromboembolism (VTE) and severe thrombocytopenia. (2016) (0)
germinal center B-cell gene expression profile The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a (2013) (0)
Bone marrow transplantation. (1984) (0)
What Our Leaders Are Reading (2005) (0)
Personalized Medicine for Patients with Lymphoma (2015) (0)
Bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma. (1990) (0)
Cancer cytogenetics. (1984) (0)
Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression. (2005) (0)
subgroups in peripheral T-cell lymphoma Gene expression signatures delineate biological and prognostic (2014) (0)
The utility of serum lactate dehydrogenase (LDH) in the follow-up of patients with diffuse large B-cell lymphoma (DLBCL). (2012) (0)
High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA. (2004) (0)
Trend Analysis of 5-Year All-Cause Mortality After Autologous Stem Cell Transplantation in Patients with Lymphoma and Multiple Myeloma (2011) (0)
Accelerated Fractionated Compared to Conventional Fractionated Salvage Radiation Therapy Improves Outcomes in Salvage Chemotherapy Refractory Diffuse Large B-Cell Lymphoma (2019) (0)
Cytosine arabinoside, vincristine and prednisone in adult acute lymphoblastic leukemia (1977) (0)
transplantation for follicular lymphoma Comparison of autologous and allogeneic hematopoietic stem cell (2013) (0)
Best Practices of Apheresis in Hematopoietic Cell Transplantation (2020) (0)
Bone marrow transplantation at the University of Nebraska Medical Center. (1993) (0)
Disparity In Clinical Outcomes Of Elderly Patients With Non-Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation According To Area Of Residence (2013) (0)
Non-Hodgkin’s Lymphoma in the Context of Antecedent Rheumatoid Arthritis: A Case Series from the Mayo Clinic and the Nebraska Lymphoma Study Group. (2004) (0)
An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012. (2013) (0)
Preliminary phase I evaluations of 2 anti-CD40 monoclonal antibodies in patients with relapsed/refractory multiple myeloma (2007) (0)
More on follicular lymphomas. (1993) (0)
Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI). (2005) (0)
Adverse Prognostic Factors in Adult Secondary Hemophagocytic Lymphohistiocytosis: Results from Two Tertiary Academic Centers (2020) (0)
Thanks to Reviewers2000 (2000) (0)
The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma - Single Institution Experience (2019) (0)
Older Adults with Acute Myeloid Leukemia (AML) Treated in a Pragmatic Trial: How Do Patients’ Function and Health-Related Quality of Life Change with Treatment? (2022) (0)
Contemporary strategies to improve outcomes for peripheral T-cell lymphoma patients following the failure of first-line therapy (2020) (0)
Current Status of Recombinant Idiotype Vaccines for the Treatment of Follicular Non-Hodgkin's Lymphoma (2002) (0)
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions. (2021) (0)
Spontaneous regression of chronic lymphocytic leukemia (2015) (0)
The current status of therapy for aggressive non-Hodgkin lymphoma (1991) (0)
Hodgkin lymphoma and the impact of age. (2008) (0)
survival in mantle cell lymphoma mRNAs that are associated with increased proliferation rate and shorter Point mutations and genomic deletions in Cyclin D1 create stable truncated (2013) (0)
Historical Perspectives of T-cell Lymphoma and Etiology Overview (2010) (0)
Risk of 30-Day Mortality and Its Association with Health System and Socioeconomic Factors in Diffuse Large B Cell Lymphoma (DLBCL) (2016) (0)
Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis (2019) (0)
No advantage for chlorambucil maintenance therapy in gastric MALT lymphoma (2009) (0)
Stem cell transplant at home: glimpse of the future. (1999) (0)
Calendar of meetings (1989) (0)
The Cancer Care Workforce in Nebraska (2014) (0)
A Single-Center Phase IIa Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (2018) (0)
Letter to the Editor: Astronomical weddings for astronomers (2008) (0)
Professionalism and cancer care. (2008) (0)
Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group (2014) (0)
Is it necessary to make clinical groupings of lymphoid neoplasms (1999) (0)
Risk of Second Primary Malignancies (SPM) in Patients with Follicular Lymphoma (FL) (2015) (0)
Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group (2015) (0)
228: Nonmyeloablative allogeneic stem cell transplantation (NST) for hematologic malignancies (HM) using pentostatin/low-dose total body irradiation (Pt-TBI) (2007) (0)
Cytosine arabinoside and thioguanine for remission maintenance of acute nonlymphoblastic leukemia of adults (1976) (0)
Treatment decisions for patients with non-Hodgkin's lymphoma: taking into account the type of lymphoma and clinical characteristics of the patient. (2002) (0)
THANKS TO REVIEWERS1999 (1999) (0)
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study. (2023) (0)
Watch and Wait, Salvage Later. (2018) (0)
Adult T-Cell Leukemia/Lymphoma: A Clinicopathologic Study of 126 Cases from the International T-Cell Lymphoma Project. (2006) (0)
From the guest editor: pressing questions in the care of patients with lymphomas. (2012) (0)
25-year survival trends of patients with lymphoma by race/ethnicity as reported to the Nebraska Lymphoma Study Group (NLSG) (2008) (0)
Impact of Bone Marrow Neuropathy on the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma (2013) (0)
Advances in the Management of Lymphoma (2002) (0)
PET-directed therapy in Hodgkin lymphoma: Ready for prime time? (2015) (0)
Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype. (2007) (0)
Non-Hodgkin's Lymphoma After Treatment of Hodgkin's Disease-Reply (1983) (0)
Recent Advances in the Treatment of Multiple Myeloma (2009) (0)
A Prognostic Model of 114 Patients with Castleman’s Disease. (2006) (0)
Molecular advances come of age. Part II. (2013) (0)
Thanks to Reviewers2005 (2005) (0)
The classification of low-grade lymphoma and the value of purine analogs (1996) (0)
Acute leukemia presenting with pericardial involvement. (1976) (0)
Reviewer Acknowledgments (2009) (0)
Preliminary results of a phase I/II study of the humanized anti-CD20 antibody IMMU-106 (hA20) in patients with relapsed non-Hodgkin lymphoma (2007) (0)
Study Identifies Clinical Factors That Predict Outcome in Aggressive Non-Hodgkin's Lymphoma (1995) (0)
Update on Treatment Options for Non-Hodgkin's Lymphoma (2006) (0)
Survival of patients with secondary acute myeloid leukemia (sAML) in Hodgkin Lymphoma (HL): A Surveillance Epidemiology and End Results (SEER) database study. (2015) (0)
The Webster/Cella Article Reviewed (1998) (0)
Role of Rituximab in the Treatment of Splenic Marginal Zone Lymphoma. (2005) (0)
Reproducibility and clinical usefulness of histologic subclassification of stage III and IV diffuse histiocytic lymphoma (DHL) treated with cyclophosphamide adriamycin, vincristine, and prednisone (CHOP) (1979) (0)
48th annual meeting of the American Society of Hematology December 9-12, 2006, Orlando, FL. (2007) (0)
Development and validation of a disease specific renal stone patient reported outcome measure (PROM) (2019) (0)
From: 43rd Annual Meeting of the American Society of Clinical Oncology; Chicago, IL, June 1-5, 2007 (2007) (0)
Association of serious adverse events with type and sponsorship of clinical trials in patients with lymphoma (2007) (0)
Transplantation for lymphoma: good for the brain as well as the body? (2012) (0)
Association of Follow-up Care Characteristics and Outcomes According to Number of Follow-up Providers Among Survivors of Hematologic Malignancies. (2009) (0)
Treatment of Stage I-II Hodgkin's Disease (2003) (0)
‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
Long Term Outcomes for Patient with Diffuse Large B-Cell (DLBCL) or Hodgkin’s Lymphoma (HL) following Autologous Stem Cell Transplant (ASCT) Who Are Disease Free at Five Years Post Transplant. (2008) (0)
MP25-16 HOLMIUM ENUCLEATION OF THE PROSTATE WITH A GLAND VOLUME OVER 200CC (2020) (0)
Marginal Z one B -Cell L ymphoma: A C linical C omparison of N odal a nd M ucosa-Associate d L ymphoid T issue T ypes (1999) (0)
PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES (2017) (0)
Recent advances in lymphoma treatment: Introduction (1991) (0)
Lymphoblastic Lymphoma A Comparison of Allogeneic and Autologous Bone Marrow Transplant for (2013) (0)
Comprar Non-Hodgkin's Lymphomas 2nd Ed | Dr. James O. Armitage M.D. | 9780781791168 | Lippincott Williams & Wilkins (2009) (0)
Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma. (2006) (0)
Role of PET Scan in Lymphomas (2014) (0)
Comprar Atlas of Clinical Hematology | Armitage, James | 9781573402842 | Springer (2008) (0)
The Impact of Histological Subtypes on Outcome in Patients with Mantle Cell Lymphoma Treated with or without Autologous Stem Cell Transplant. (2007) (0)
Serial cytogenetic studies in malignant lymphoma (1985) (0)
How I treat How I treat patients with diffuse large B-cell lymphoma (2007) (0)
Effects of antisense oligonucleotides B3A2 and B2A2 on K562 cell line and normal human peripheral blood progenitor cells (1994) (0)
Chapter 26 – Peripheral T-Cell Lymphoma (2006) (0)
PRIMARY EXTRANODAL MARGINAL ZONE LYMPHOMA of the LUNG (BALT-LYMPHOMA): Results of a Retrospective Analysis on Behalf of IELSG (2010) (0)
Recurrent Mantle Cell Lymphoma Isolated to the Testis After 19-Year Remission: A Case Report and Review of the Literature. (2022) (0)
[Autotransplantation in lymphomas: is it effective?]. (1992) (0)
Rituximab Improves Efficacy of Chemotherapy for Follicular Lymphomas (2002) (0)
Supportive Care Strategies: Optimizing Transplant Care (2020) (0)
Trends in use of radiation therapy from 2000 to 2012 using National Cancer Database (NCDB): Is less the new more? (2015) (0)
Geographic Distribution of the Peripheral T‐cell Lymphomas (2021) (0)
Rituximab-CHOP (R-CHOP) plus maintenance pegylated interferon (PegInt) for patients (pts) with follicular lymphoma (FL) and no prior anthracycline-based therapy (2008) (0)
Autotransplant Activity 1989–1994 (2020) (0)
Combined Chemotherapy and Radiation Is Associated with Improved Outcomes in Stage I Follicular Lymphoma. (2004) (0)
Hematopoietic cell transplants for indolent lymphomas (2017) (0)
Non‐Hodgkin Lymphoma – State of the Art and Next Questions: 088‐NHL‐01 (2017) (0)
Autotransplants f or H odgkin's D isease i n P atients N ever Achieving R emission: A R eport F rom t he A utologous B lood and M arrow T ransplant R egistry (2011) (0)
The Cancer Care Workforce in Nebraska, 2008-2012 (2014) (0)
27. Treating patients with lymphoma as a paradigm for “personalized medicine” (2018) (0)
Mature Nodal and Extranodal T-Cell and NK-Cell Lymphoma (2009) (0)
Lymphoma and Leukemia in Pregnancy (1999) (0)
transplantation involved- field radiotherapy and BEAC with autologous bone marrow Parma international protocol: pilot study of DHAP followed by (2011) (0)
Autologous Bone Marrow Transplantation in Hodgkin Lymphoma (1990) (0)
Atypical lymphoid hyperplasia of cervix with clonal IGH/IGK and BCL6 gene rearrangements. (2020) (0)
2000 U pdate o f R ecommendations f or t he U se o f Hematopoietic C olony-Stimulati ng F actors: E vidence- Based, C linical P ractice G uidelines (2000) (0)
Commentary (Armitage): Quality of Life in Low-Grade Non-Hodgkin’s Lymphoma (1998) (0)
The durability of complete remissions (CR) induced by cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) in diffuse histiocytic lymphoma (DHL) (1981) (0)
Referee Acknowledgement for 2013 (2014) (0)
Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma. (2008) (0)
Dose intensity and diffuse large cell lymphoma (1995) (0)
Care of the patient with hematologic malignancy: a point of view. (1975) (0)
Does size matter? Holmium enucleation of the prostate with a gland volume over 200cc: Techniques and outcomes (2020) (0)
Autotransplants in Advanced Non-Hodgkin Lymphoma: Are They Effective? (1992) (0)
Impact of age on outcome of autologous stem cell transplant for follicular and diffuse large B cell lymphoma (2004) (0)
LYMPHOID NEOPLASIA Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma (2010) (0)
Classification and treatment of lymphomas. (2002) (0)
Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL) (2015) (0)
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma (2019) (0)
The Role of Autografting in Low-Grade Lymphoma (2020) (0)
What Our Leaders Are Reading. (2005) (0)
SERUM IG ABNORMALITIES IN MANTLE CELL LYMPHOMA. AUTHORS' REPLY (1997) (0)
Influence of rituximab (R) on survival of patients (pts) with grade 1 and 2 follicular lymphoma (FL 1-2) over the past three decades. (2011) (0)
Real Personalized Medicine. (2016) (0)
Clinical aspects of follicular lymphoma and the relevance of grading (1999) (0)
Comparison of Front-Line Chemotherapy for Intermediate Grade and Follicular Non-Hodgkin’s Lymphoma Using the CAP-BOP Regimens (1996) (0)
Clinical significance of cMYC Rearrangement in Diffuse Large B-cell Lymphoma (2011) (0)
Secondary acute myeloid leukemia (sAML) among patients with myeloproliferative neoplasm (MPN) (2015) (0)
Analysis of gene expression in normal and malignant lymphocytes using the Lymphochip cDNA microarray (1999) (0)
Phase I/II trial of pralatrexate in patients with chemotherapy-resistant precursor and peripheral T-cell lymphomas (2007) (0)
Nebraska Lymphoma Study Group (NLSG) results of treatment for non-Hodgkin’s lymphoma (NHL) in patients (pts) aged 80 years or greater (2008) (0)
Any drug that works has a target (2006) (0)
Bone Marrow Transplantation for Patients with Malignant Lymphoma (1993) (0)
The role of granulocyte colony stimulating factor in bone marrow transplantation (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With James Olen Armitage?

James Olen Armitage is affiliated with the following schools:

James Olen Armitage's Academic­Influence.com Rankings

James Olen Armitage's Degrees

Why Is James Olen Armitage Influential?

James Olen Armitage's Published Works

Published Works

What Schools Are Affiliated With James Olen Armitage?

James Olen Armitage's AcademicInfluence.com Rankings